Influence of Body Mass Index on Assisted Reproductive Techniques
Abstract
Objective. To analyze the relationship between the Body Mass Index in women and the results obtained in assisted reproductive techniques.
Methods. A non-experimental, cross-sectional, descriptive and correlational design was carried out through an analysis of secondary data in several assisted reproduction clinics from Spain. 3,273 medical records of women undergoing In Vitro Fertilization between 2015 and 2018 were analyzed. Data on affiliation and treatment initiation, anthropometric data, personal history, current diseases, primary and secondary infertility, as well as the reference parameters to the results after the assisted reproduction treatment were collected. The statistical analysis was performed using SPSS v19.0 software.
Results. A total of 798 women (24.42%) had a BMI values ≥ 25. The overweight women achieved a lower number of oocytes retrieved and fertilized, as well as fewer embryos obtained. The women with normal weight achieved a lower number of mature oocytes and those with low weight had a lower fertilization rate.
Conclusions. It has been found that the results obtained in assisted reproductive techniques are related to women's Body Mass Index.
Downloads
References
Damario M. General Aspects of fertility and Infertility. Hertfordshire, United Kingdom: Editorial Human Press; 2014. Doi: https://doi.org/10.1016/j.rbmo.2019.10.008.
Viera-Molina M, & Guerra-Martín MD. Análisis de la eficacia de las técnicas de reproducción asistida: una revisión sistemática. An Sist Sanit Navar 2018; 41 (1): 107-116. Doi: https://dx.doi.org/10.23938/assn.0254
Bonfill X, & Urrutia G. Análisis y generación de evidencias en reproducción medicamente asistida [Tesis Doctoral]. España, Universidad Autónoma de Barcelona; 2015. https://ddd.uab.cat/pub/tesis/2015/hdl_10803_322783/rbgv1de1.pdf
Matorras WR. La infertilidad en España: Situación actual y perspectivas. Madrid: Editorial Imago Concept & Image Development; 2011. https://www.sefertilidad.net/docs/biblioteca/libros/libroBlanco.pdf
Matorras R, & Hernández J. Estudio y tratamiento de la pareja estéril: Recomendaciones de la Sociedad Española de Fertilidad. Madrid: Adalia; 2007. https://www.sefertilidad.net/docs/biblioteca/recomendaciones/completo.pdf
Brewer CJ, & Balen A. The adverse effects of obesity on conception and implantation. Reproduction 2010;140 (3): 347–364. Doi: https://doi.org/10.1530/REP-09-0568
Levens E, & Skarulis M. Assessing the role of endometrial alteration among obese patients undergoing assisted reproduction. Fertility and sterility 2008; 89 (6):1606–1608. Doi: https://doi.org/10.1016/j.fertnstert.2007.03.079
Luke B, Brown M, Stern J, Missmer S, Fujimoto V, & Leach R. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Human Reproduction 2011; 26 (1): 245-252. Doi: https://doi.org/10.1093/humrep/deq306
Leary C, Leese HJ, & Sturmey RG. Human embryos from overweight and obese women display phenotypic and metabolic abnormalities. Human Reproduction 2015; 30 (1): 122-132. Doi: https://doi.org/10.1093/humrep/deu276
Ozekinci M, Seven A, Olgan S, Sakinci M, Keskin U, Akar ME, Ceyhan ST, Ergun A. Does obesity have detrimental effects on IVF treatment outcomes? BMC Women’s Health 2015; 19 (15): 61. Doi: https://doi.org/10.1186/s12905-015-0223-0
Organización Mundial de la Salud. Obesity: preventing and managing the global epidemic [Internet]. Geneva; 2000. [Citado 03/2020]. Recuperado a partir de: https://apps.who.int/iris/handle/10665/42330
Zegers-Hochschild F, Crosby J, Musri C, Souza M, Martinez G, Silva A, Mojarra J, Masoli D, & Posada N. Assisted reproductive techniques in Latin America: The Latin American Registry, 2017. JBRA Assisted Reproduction 2020; 24 (3): 362-378. Doi: https://doi.org/10.5935/1518-0557.20200029
Chavarro J, Ehrlich S, Colaci D, Wright D, Toth T, Petrozza JC, & Hauser R. Body mass index and short-term weight change in relation to treatment outcomes in women undergoing assisted reproduction. Fertility and Sterility 2012; 98 (1): 109–116. Doi: https://doi.org/10.1016/j.fertnstert.2012.04.012
Pisarska MD, Chan JL, Lawrenson K, Gonzalez TL, & Wang ET. Genetics and Epigenetics of Infertility and Treatments on Outcomes. The Journal of clinical endocrinology and metabolism 2019; 104 (6): 1871–1886. Doi: https://doi.org/10.1210/jc.2018-01869
Liu Y, & Zhang W. Association between body mass index and endometriosis risk: a meta-analysis. Oncotarget 2017; 8 (29): 46928–46936. Doi: https://doi.org/10.18632/oncotarget.14916
Cui N, Wang H, Wang W, Zhang J, Xu Y, Jiang L, Yang A, & Hao G. Impact of Body Mass Index on Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection Among Polycystic Ovarian Syndrome Patients. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 2016; 39 (5): 1723–1734. Doi: https://doi.org/10.1159/000447873
McCormick B, Thomas M, Maxwell R., Williams D, & Aubuchon M. Effects of polycystic ovarian syndrome on in vitro fertilization embryo transfer outcomes are influenced by body mass index. Fertility and Sterility 2008; 90 (6): 2304-2309. Doi: https://doi.org/10.1016/j.fertnstert.2007.10.077
Marquard KL, Stephens SM, Jungheim ES, Ratts VS, Odem RR, Lanzendorf S, & Moley KH. Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertility and sterility 2011; 95(6): 2146–2149.e1. Doi: https://doi.org/10.1016/j.fertnstert.2010.10.026
Chiaffarino F, Parazzini F, Vecchia C, Chatenoud L, Di Cintio E, & Marsico S. Diet and uterine myomas. Obstet Gynecol 1999; 94 (3): 395-398. Doi: 10.1016/s0029-7844(99)00305-1
Sparic P, Mirkovic L, Malvasi A, & Tinelli A. Epidemiology of Uterine Myomas: A Review. Fertility & Sterility 2016; 9 (4): 424-435. Doi: 10.22074/IJFS.2016.4599
Lethaby AE, & Vollenhoven BJ. Fibroids (uterine myomatosis, leiomyomas). BMJ clinical evidence 2007: 0814.
Parker W. Etiology, symptomatology, and diagnosis of uterine myomas. Fertility & Sterility 2007; 87 (4): 725-736. Doi: https://doi.org/10.1016/j.fertnstert.2007.01.093
Benksim A, Elkhoudri N, Ait Addi R, Baali A, & Cherkaoui M. Difference between Primary and Secondary Infertility in Morocco: Frequencies and Associated Factors. Royan Institute International Journal of Fertility and Sterility 2017; 12 (2): 141-146. Doi: 10.22074/ijfs.2018.5188
Musoles F, Castillo JC, Raga F, Caballero O, Machado LE, Pérez-Panades J, Bonilla F, Dolz M. Valores de hormona antimülleriana (HAM) y recuento de folículos antrales (RFA) en casos con fallo reproductivo previo. Procesos de obstetricia y ginecología 2012; 55 (1): 8-14. Doi: https://doi.org/10.1016/j.pog.2011.08.012
Yang W, Yang R, Lin M, Yang Y, Song X, Zhang J, et al. Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome. Reprod Biol Endocrinol 2018; 16:119. Doi: https://doi.org/10.1186/s12958-018-0438-7
Beydoun HA, Stadtmauer L, Beydoun MA, Russell H, Zhao Y, Oehninger S. Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies. Reproductive BioMedicine Online 2009; 18 (6): 856-863. Doi: 10.1016/s1472-6483(10)60037-5.
Orvieto R, Meltcer S, Nahum R, Rabinson J, Anteby EY, Ashkenazi J. The influence of body mass index on in vitro fertilization outcome. International Journal of Gynecology & Obstetrics 2009; 104 (1): 53-55. Doi: https://doi.org/10.1016/j.ijgo.2008.08.012
Sarais V, Pagliardini L, Rebonato G, Papaleo E, Candiani M, Vigano P. A Comprehensive Analysis of Body Mass Index Effect on in Vitro Fertilization Outcomes. Nutrients 2016; 8: 109. Doi: https://doi.org/10.3390/nu8030109
Loveland JB, McClamrock HD, Malinow AM, Sharara FI. Increased Body Mass Index Has a Deleterious Effect on In Vitro Fertilization Outcome. Journal of Assisted Reproduction and Genetics 2001; 18 (7): 382-386. Doi: https://doi.org/10.1023/A:1016622506479
Munares-García O, Gómez-Guizado G, Barboza-Del Carpio J, Sánchez-Abanto J. Limitaciones del análisis secundario de bases de datos - Réplica [carta]. Rev Peru Med Exp Salud Publica 2013; 30 (1):152-3.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
